Aakaar Medical Technologies Ltd
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]
- Market Cap ₹ 94.2 Cr.
- Current Price ₹ 66.5
- High / Low ₹ 105 / 46.0
- Stock P/E 14.2
- Book Value ₹ 38.5
- Dividend Yield 0.00 %
- ROCE 18.5 %
- ROE 17.1 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 65.2% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 203 days.
- Working capital days have increased from 130 days to 199 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | 66.96 | |
| 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.84 | 56.64 | |
| Operating Profit | 2.88 | 0.90 | 2.40 | 3.53 | 5.00 | 9.74 | 10.32 |
| OPM % | 12.58% | 7.23% | 12.33% | 10.77% | 10.84% | 15.82% | 15.41% |
| 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | 0.80 | |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 | 1.80 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 | 0.13 |
| Profit before tax | 2.50 | 0.76 | 2.21 | 3.10 | 3.88 | 8.09 | 9.19 |
| Tax % | 26.80% | 28.95% | 26.24% | 30.65% | 26.29% | 25.22% | 27.86% |
| 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.04 | 6.64 | |
| EPS in Rs | 183.00 | 54.00 | 23.14 | 30.71 | 41.00 | 5.80 | 4.69 |
| Dividend Payout % | 0.00% | 0.00% | 34.57% | 24.42% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 27% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 65% |
| 3 Years: | 46% |
| TTM: | 10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 23% |
| Last Year: | 17% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.70 | 0.70 | 0.70 | 10.42 | 14.17 |
| Reserves | 6.75 | 7.30 | 7.33 | 8.96 | 11.84 | 12.78 | 40.38 |
| 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | 18.53 | |
| 3.56 | 3.03 | 6.15 | 7.70 | 6.42 | 8.17 | 6.34 | |
| Total Liabilities | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 79.42 |
| 0.06 | 0.04 | 0.20 | 0.36 | 0.28 | 0.24 | 0.69 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.47 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 15.76 | 14.16 | 17.80 | 22.87 | 33.73 | 53.87 | 78.73 | |
| Total Assets | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 79.42 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -0.38 | 4.31 | 0.48 | -2.93 | -8.04 | -5.41 | -8.36 | |
| 0.10 | 0.37 | -0.23 | -0.32 | -0.04 | -0.05 | 0.05 | |
| 0.28 | -2.00 | -0.81 | 1.17 | 8.19 | 10.71 | 18.80 | |
| Net Cash Flow | 0.00 | 2.68 | -0.55 | -2.08 | 0.11 | 5.25 | 10.48 |
| Free Cash Flow | -0.40 | 4.30 | 0.29 | -3.19 | -8.09 | -5.49 | -8.94 |
| CFO/OP | 10% | 503% | 47% | -54% | -136% | -35% | -59% |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 117.84 | 135.85 | 104.42 | 113.91 | 128.71 | 165.96 | 202.94 |
| Inventory Days | 234.33 | 366.16 | 281.70 | 273.75 | 247.29 | 202.47 | 255.63 |
| Days Payable | 28.20 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 | 24.33 |
| Cash Conversion Cycle | 323.97 | 403.05 | 320.92 | 326.10 | 344.26 | 319.59 | 434.24 |
| Working Capital Days | 189.44 | 238.25 | 105.17 | 101.55 | 93.96 | 96.85 | 198.91 |
| ROCE % | 8.25% | 20.93% | 25.79% | 23.28% | 26.66% | 18.47% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Doctor Reach (Cumulative) Number |
|
|||
| Number of Medical Representatives (MRs) Number |
||||
| Revenue per MR (Productivity) INR Lakhs |
||||
| Total SKU Count Number |
||||
| Device Consumables Sold Units |
||||
| New Customers Added Number |
||||
| Number of Billed Customers Number |
||||
Extracted by Screener AI
Documents
Announcements
-
Copy of Newspaper Publication
6 June 2026 - Newspaper publication issued for 13th AGM on 30 June 2026 via VC/OAVM.
-
Shareholders meeting
5 June 2026 - 13th AGM on 30 June 2026; seek ESOPs up to 11,33,825 shares and capital increase to ₹15.40 crore.
-
Outcome of Board Meeting
28 May 2026 - FY26 audited results approved; profit rose to 663.76 lakh, and Dilip Meswani reappointed as director.
-
Statement of deviation(s) or variation(s) under Reg. 32
28 May 2026 - Company reports no deviation in IPO proceeds use for year ended 31 March 2026.
-
Outcome of Board Meeting
25 May 2026 - Board approved ESOP 2026 and raised authorised capital from ₹15 crore to ₹15.4 crore on May 25, 2026.
Annual reports
Concalls
-
May 2026Transcript PPT
-
Nov 2025Transcript PPT
Business Profile[1]
Aakaar Medical Technologies operates in the medical aesthetics segment, offering a portfolio of aesthetic products and devices through a B2B model. It caters primarily to dermatologists, plastic surgeons, and aesthetic physicians across India.